Wild-type p53 blocks glycolytic flux and promotes oxidative phosphorylation (OXPHOS) by downregulating glycolytic enzymes and upregulating mitochondrial proteins [19], and p53-deficient cancer cells tend to undergo metabolic shifts toward glycolysis [20,21]. The gene discussed is TP53; the disease is cancer.